• Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans

Subscribe to Updates

Get the latest finance news and updates directly to your inbox.

Top News

Why Entrepreneurs Are Choosing StackSkills Unlimited at $19.97

February 2, 2026

How This Writing Practice Transformed My Direction in Life

February 2, 2026

Mark Cuban Wishes He Invested in This Company Earlier

February 2, 2026
Facebook Twitter Instagram
Trending
  • Why Entrepreneurs Are Choosing StackSkills Unlimited at $19.97
  • How This Writing Practice Transformed My Direction in Life
  • Mark Cuban Wishes He Invested in This Company Earlier
  • You Don’t Need Better AI—You Need Better Prompts
  • Trump Accounts hit 1 million sign-ups after Nicki Minaj White House summit appearance, Bessent says
  • This Common Drink Can Fight Disease and Slow Aging — but Only If You Drink It Right
  • Why Women Workers Are Facing the Biggest AI Risk — and What They Should Do Now
  • Why Protecting Your AI Data Should Be a Top Priority
Monday, February 2
Facebook Twitter Instagram
Indenta
Subscribe For Alerts
  • Home
  • News
  • Personal Finance
    • Savings
    • Banking
    • Mortgage
    • Retirement
    • Taxes
    • Wealth
  • Make Money
  • Budgeting
  • Burrow
  • Investing
  • Credit Cards
  • Loans
Indenta
Home » Stocks to Watch: Delta Apparel, Oddity Tech, ALX Oncology
Investing

Stocks to Watch: Delta Apparel, Oddity Tech, ALX Oncology

News RoomBy News RoomOctober 3, 202312 Views0
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Email Tumblr Telegram

By Ben Glickman

Delta Apparel said it had received an unsolicited offer to acquire its Salt Life unit. The apparel company did not say the terms of the offer, but said it would conduct a review of options for the business. Shares rise 20%, to $7.90, after-hours.

Oddity Tech said it expected its best-ever third quarter after releasing some preliminary results. The company expects revenue to grow 29% to 31%, higher than prior guidance of 18% to 23% growth. Shares rise 12%, to $31.50, after-hours.

ALX Oncology will release interim Phase 2 trial results on a call Tuesday. The company said it would discuss data from its trial of evorpacept in the treatment of HER-2-positive gastric cancer, the results of which are expected in the fourth quarter. Shares rise 22%, to $5.88, after-hours.

Write to Ben Glickman at [email protected]

Read the full article here

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Articles

How This Writing Practice Transformed My Direction in Life

Investing February 2, 2026

Comparing AI Models With This Tool Can Save Your Business Time and Money

Investing February 1, 2026

Fear and Uncertainty Stopped Me From Investing — Here’s the Simple Framework I Used to Never Hesitate Again

Investing January 31, 2026

Why Entrepreneurs Should Think Like Bitcoin Miners

Investing January 30, 2026

4 Documentaries Every Serious Investor Should Watch

Investing January 29, 2026

The AI Power Shift Every Founder Needs to Prepare For

Investing January 28, 2026
Add A Comment

Leave A Reply Cancel Reply

Demo
Top News

How This Writing Practice Transformed My Direction in Life

February 2, 20261 Views

Mark Cuban Wishes He Invested in This Company Earlier

February 2, 20261 Views

You Don’t Need Better AI—You Need Better Prompts

February 2, 20260 Views

Trump Accounts hit 1 million sign-ups after Nicki Minaj White House summit appearance, Bessent says

February 2, 20260 Views
Don't Miss

This Common Drink Can Fight Disease and Slow Aging — but Only If You Drink It Right

By News RoomFebruary 1, 2026

Drinking tea daily may be giving you a significant health boost, according to recent research.…

Why Women Workers Are Facing the Biggest AI Risk — and What They Should Do Now

February 1, 2026

Why Protecting Your AI Data Should Be a Top Priority

February 1, 2026

Comparing AI Models With This Tool Can Save Your Business Time and Money

February 1, 2026
About Us

Your number 1 source for the latest finance, making money, saving money and budgeting. follow us now to get the news that matters to you.

We're accepting new partnerships right now.

Email Us: [email protected]

Our Picks

Why Entrepreneurs Are Choosing StackSkills Unlimited at $19.97

February 2, 2026

How This Writing Practice Transformed My Direction in Life

February 2, 2026

Mark Cuban Wishes He Invested in This Company Earlier

February 2, 2026
Most Popular

The U.S. dollar just formed a ‘golden cross,’ which could cause trouble for the rest of the globe

September 23, 202311 Views

Boston Properties to sell interest in two assets valued at about $1.7 billion

November 14, 202310 Views

Stocks to Watch: Delta Apparel, Oddity Tech, ALX Oncology

October 3, 20239 Views
Facebook Twitter Instagram Pinterest Dribbble
  • Privacy Policy
  • Terms of use
  • Press Release
  • Advertise
  • Contact
© 2026 Inodebta. All Rights Reserved.

Type above and press Enter to search. Press Esc to cancel.